Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer [0.03%]
间变性淋巴瘤激酶重排非小细胞肺癌的治疗进展
Hirva Mamdani,Shadia I Jalal
Hirva Mamdani
Lucia Anna Muscarella,Antonio Rossi
Lucia Anna Muscarella
Loss of flexion during bronchoscopy: a physical experiment and case study of commercially available systems [0.03%]
支气管镜检查中弯曲度丧失的物理实验及商用系统的病例研究
Conor O&#x;Shea,Kashif Ali Khan,Josef Tugwell et al.
Conor O&#x;Shea et al.
During routine endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) procedures, especially with biopsy of lymph nodes in or around the left upper lobe, frequent reports have noted the loss of ultrasound image and nee...
Advanced squamous lung cancer: therapeutic options, future directions, unmet needs and results of a monocentric survey [0.03%]
晚期肺鳞癌的治疗选择、未来方向及未满足的需求以及单中心调查结果
Valentina Bertaglia,Stefania Vallone,Maria Vittoria Pacchiana et al.
Valentina Bertaglia et al.
Lung cancer is the leading cause of cancer-related deaths in worldwide, and NSCLC represents around 85% of all lung cancers. Squamous cell lung cancer (SqCLC) is the second most common subtype and it is challenging to treat. New options hav...
Barbara Legius,Kristiaan Nackaerts
Barbara Legius
Thromboembolic events (TEEs) are frequent in cancer patients, especially venous thrombosis. Arterial thrombosis is less frequent. Chemotherapy increases the risk of these TEEs. Although TEEs are often reported, intestinal ischemia is a rare...
Case Reports
Lung cancer management. 2017 Dec;6(3):87-91. DOI:10.2217/lmt-2017-0016 2017
How equitable is access to treatment for lung cancer patients? A population-based review of treatment practices in Ontario [0.03%]
肺癌患者的治疗机会公平吗？基于人口的安大略省治疗实践回顾
William K Evans,Jennifer Stiff,Kelly J Woltman et al.
William K Evans et al.
Aim: Guideline concordance is one of the metrics used by the Cancer Quality Council of Ontario and Cancer Care Ontario to assess the quality of cancer care and to drive quality improvement. ...
Thomas Newsom-Davis
Thomas Newsom-Davis
A significant proportion of lung cancer patients are first diagnosed as part of an emergency presentation (EP) to acute medical services. This route to diagnosis is a strong negative predictor of survival, and is associated with age, depriv...
The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer [0.03%]
血清和支气管肺泡灌洗液中脂联素水平对晚期非小细胞肺癌预后价值的研究
Paraskevi Boura,Dimitra Grapsa,Stylianos Loukides et al.
Paraskevi Boura et al.
Aim: We aimed to explore the prognostic implications of adiponectin (APN) levels in the serum and bronchoalveolar lavage (BAL) of patients with advanced NSCLC. ...
Patient selection for thoracic radiotherapy in extensive-stage small-cell lung cancer [0.03%]
广泛期小细胞肺癌胸部放疗的患者选择
Mark T Corkum,George B Rodrigues
Mark T Corkum
Treatment of extensive-stage small-cell lung cancer remains a challenge with poor local control and overall survival. Chemotherapy is the mainstay of treatment, consisting of a combination of a platinum agent plus etoposide. The role of con...
Patient with typical carcinoid initially diagnosed as high-grade neuroendocrine carcinoma [0.03%]
最初被诊断为高级别神经内分泌癌的类癌患者
Sean Warsch,Mohammad Jahanzeb
Sean Warsch
We report the case of a patient initially diagnosed with a high-grade neuroendocrine carcinoma, which 5 years later was determined to have a low-grade typical carcinoid. The patient received radiotherapy and numerous chemotherapy regimens f...
Case Reports
Lung cancer management. 2017 Nov;6(2):41-45. DOI:10.2217/lmt-2017-0010 2017